FDA Clearance Tracker · P830055-S346
ATTUNE Revision Rotating Platform (RP) Knee System
Last checked: Nov 20, 2026Latest source record: Dec 18, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 18, 2025
Approved
Time to decision
177 days
Received Jun 24, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P830055-S346
- Device name
- ATTUNE Revision Rotating Platform (RP) Knee System
- Applicant
- Depuy, Inc.
- Applicant location
- Warsaw, IN
- Received
- Jun 24, 2025
- Decided
- Dec 18, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P830055
Device type
- Device type
- Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing (NJL)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the ATTUNE Revision Rotating Platform (RP) Thick Tibial Base as part of the ATTUNE Revision Rotating Platform (RP) Knee System.
Source documents
Other decisions for Depuy, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.